May 27, 2025
Parkinson’s disease is a complex and progressive neurodegenerative disorder that affects millions worldwide, with its prevalence expected to rise due to aging populations and environmental factors. Characterized by a gradual decline in motor and non-motor functions, the disease significantly impacts the quality of ...
Read More...
Nov 18, 2024
Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It affects about 10 million people worldwide. The average age of onset for Parkinson’s disease is around 60; however, approximately 10-15% of patients experience early-onset PD before the age of 50. In 2023, there...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper